Growth Metrics

Resmed (RMD) Shares Outstanding (Diluted Average) (2020 - 2025)

Resmed's Shares Outstanding (Diluted Average) history spans 9 years, with the latest figure at $146.6 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) fell 0.57% year-over-year to $146.6 million; the TTM value through Dec 2025 reached $146.6 million, down 0.57%, while the annual FY2025 figure was $147.3 million, 0.14% changed from the prior year.
  • Shares Outstanding (Diluted Average) reached $146.6 million in Q4 2025 per RMD's latest filing, roughly flat from $146.9 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $147.6 million in Q3 2024 to a low of $146.4 million in Q1 2021.
  • Average Shares Outstanding (Diluted Average) over 5 years is $147.2 million, with a median of $147.3 million recorded in 2025.
  • Peak YoY movement for Shares Outstanding (Diluted Average): rose 0.55% in 2021, then fell 0.57% in 2025.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $147.0 million in 2021, then grew by 0.22% to $147.4 million in 2022, then rose by 0.12% to $147.5 million in 2023, then decreased by 0.04% to $147.5 million in 2024, then fell by 0.57% to $146.6 million in 2025.
  • Per Business Quant, the three most recent readings for RMD's Shares Outstanding (Diluted Average) are $146.6 million (Q4 2025), $146.9 million (Q3 2025), and $147.3 million (Q2 2025).